Submitting Update of Monotherapy to ESMO | Closure of ATLANTIS Trial in Small Cell

Submitting Update of Monotherapy to ESMO | Closure of ATLANTIS Trial in Small Cell

Annual-Meeting

2 years
167 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Pascal Besman, Chief Operating Officer of PharmaMar, talks about Submitting Update of Monotherapy to ESMO | Closure of ATLANTIS Trial in Small Cell at Annual Meeting 2018
Up Next Autoplay